US Patent 9371396 Anti-CD22 anti-idiotypic antibodies and uses thereof
Patent 9371396 was granted and assigned to SinoMab Bioscience Ltd. on June, 2016 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 16, 2013
Date of Patent
June 21, 2016
Patent Applicant
Patent Application Number
14407988
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9371396 Anti-CD22 anti-idiotypic antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
